SPS - Specialist Pharmacy Service
The first stop for professional medicines advice
About
Log in
Register
NHS
Guidance
Guidance
Guidance index
COVID-19
PGDs
Administering
Cautions and contraindications
Dosing
Switching
Interactions
Medication Safety
Safety in breastfeeding
Safety in pregnancy
Temperature management
Excipients
Swallowing difficulties
Stability of cytotoxics
Aseptic services
Intrathecal administration
Manufacturing and preparation
Unlicensed medicines
Homecare
ATMPs
Clinical Trials
Medical gases
Record keeping
Search Guidance
Guidance by Care Setting
Adults
Care homes
Care of the elderly
Community Health Services
Critical care
Dentistry
Emergency medicine and urgent care
Health and Justice
Neonates
Occupational Health
Paediatrics
Palliative and End of Life Care
Primary Care and PCNs
Transfer of care
Trusts
Guidance by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Ear, nose and throat disorders
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Mental health and illness
Musculo-skeletal disorders
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Surgery
Vaccinating
Wounds and injuries
Events
Events
Events index
Next events
Past Events
Search Events
Events by Care Setting
Care homes
Care of the elderly
Community Health Services
Health and Justice
Neonates
Paediatrics
Palliative and End of Life Care
Primary Care and PCNs
Transfer of care
Events by Guidance area
Adverse effects
Aseptic services
Medication Safety
Patient Group Directions
Safety in Breastfeeding
Safety in Pregnancy
Supply
Events by Specialty
Cardiovascular system disorders
Diabetes
Endocrine system disorders
Gastrointestinal disorders
Infection and infectious diseases
Learning disabilities
Mental health and illness
Neurological disorders
Respiratory disorders
Podcasts
Podcasts
Podcasts index
Planning
Planning
Planning index
Annual medicines planning
Biosimilars Updates
Search Medicines planning
Planning by Care Setting
Adults
Care homes
Care of the elderly
Community Health Services
Health and Justice
Palliative and End of Life Care
Primary Care and PCNs
Transfer of care
Trusts
Planning by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Ear, nose and throat disorders
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Liver disorders
Mental health and illness
Musculo-skeletal disorders
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Vaccinating
Training
Training
Training index
All Training and Development
Breastfeeding
Cardiovascular disease
Complementary medicines
Kidney disorders
Polypharmacy
Medication safety
Pregnancy
Search Training and Development
Publications
Publications
Publications index
RMOC Recommendations and Resources
Newsletters
Bulletins and summaries
Research and audits
Search Publications
Publications by Care Setting
Care homes
Community Health Services
Emergency medicine and urgent care
Health and Justice
Occupational Health
Primary Care and PCNs
Transfer of care
Trusts
Publications by Specialty
Infection and infectious diseases
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Sexual health
Tools
Medicines Tools
Medicines Tools index
Monitoring
Medicines Supply
MCA Stability
Search
Home
Search
Eyes and vision, Medicines planning
27 results
Applied filters
Eyes and vision
Medicines planning
Filter
Guidance
(21)
Safety in Breastfeeding
(18)
Temperature management
(9)
Stability outside the fridge
(9)
Medicine
(26)
Aciclovir
(1)
Adalimumab
(1)
Aflibercept
(1)
Atropine
(1)
Azithromycin
(1)
Bevacizumab
(1)
Bimatoprost
(1)
Brolucizumab
(1)
Ciclosporin
(1)
Ciprofloxacin
(1)
Eculizumab
(1)
Latanoprost
(1)
Levobunolol
(1)
Levofloxacin
(1)
Mercaptamine
(1)
Moxifloxacin
(1)
Nedocromil
(1)
Ocriplasmin
(1)
Ranibizumab
(4)
Ravulizumab
(1)
Sirolimus
(1)
Tafluprost
(1)
Tobramycin
(1)
Medicines planning
(27)
Biosimilars
(4)
New Medicines
(16)
CCG commissioned new medicines
(14)
NHS England commissioned new medicines
(5)
Pre-registration new medicines (UK/EU)
(6)
Patent expiries
(19)
Specialty
(27)
Allergy and immunology
(1)
Anaesthesia and pain
(1)
Cancers
(4)
Cardiovascular system disorders
(1)
Eyes and vision
(27)
Gastrointestinal disorders
(1)
Haematological disorders
(3)
Infection and infectious diseases
(6)
Musculo-skeletal disorders
(4)
Nutritional and metabolic disorders
(1)
Respiratory disorders
(2)
Skin disorders
(4)
Preparing to use ranibizumab biosimilar
29 June 2022
·
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
Good governance when implementing ranibizumab biosimilar
29 June 2022
·
Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance
The licence and supporting evidence for ranibizumab biosimilar
29 June 2022
·
Three licensed ranibizumab biosimilars are available: Byooviz, Ongavia and Ximluci. Learn about the licensed indications and supporting evidence
Faricimab
Ravulizumab
Brolucizumab
Adalimumab
Bevacizumab
Sirolimus
Ciclosporin
1
2
3
Next